Cancer vaccines: After 100 years of setbacks, are we finally getting closer?

My key takeaways from #ESMO2026:

• Personalized mRNA vaccines may generate durable T-cell immunity, even in low-TMB tumors.
• Promising signals in pancreatic cancer and melanoma.
• Phase III validation and broader access remain critical.

The next frontier in precision oncology?
@myESMO #esmo2026 #mrna #cancer